Related Experiment Video
Updated: Jul 19, 2026

Methods to Study Lipid Alterations in Neutrophils and the Subsequent Formation of Neutrophil Extracellular Traps
Published on: March 29, 2017
Immune complexes and IFN-gamma decrease cholesterol 27-hydroxylase in human arterial endothelium and macrophages
A B Reiss1, N W Awadallah, S Malhotra
1Department of Medicine, New Bellevue 16N28, New York University School of Medicine, 550 First Avenue, New York, NY 10016, USA. reissa01@popmail.med.nyu.edu
Insights
Immune reactants like IFN-gamma and C1q-bound immune complexes reduce cholesterol 27-hydroxylase expression, hindering cholesterol removal and potentially contributing to atherosclerosis development.
Area of Science:
- Biochemistry
- Immunology
- Cardiovascular Research
Background:
- Cholesterol 27-hydroxylase is crucial for removing arterial cholesterol, acting as a defense against atherosclerosis.
- Immune system involvement in atherosclerosis pathogenesis is increasingly recognized.
Purpose of the Study:
- To investigate the impact of specific immune reactants on cholesterol 27-hydroxylase expression in cells relevant to atherosclerosis.
- To elucidate the role of complement fixation and C1q receptors in this immune-mediated regulation.
Main Methods:
- Assessing the effect of interferon-gamma (IFN-gamma) and immune complexes (ICs) on cholesterol 27-hydroxylase expression.
- Utilizing human aortic endothelial cells, peripheral blood mononuclear cells, macrophages, and THP-1 cell line.
- Investigating the role of complement fixation and C1q receptor (C1qRp) interaction.
Main Results:
- IFN-gamma and C1q-bound ICs, but not IL-1 or TNF, significantly diminished cholesterol 27-hydroxylase expression.
- Immune complex-mediated down-regulation required complement fixation and interaction with C1qRp.
- These effects were observed across multiple cell types, including endothelial cells and macrophages.
Conclusions:
- Specific immune reactants can impair the body's cholesterol-clearing mechanisms in the arterial wall.
- C1q receptors and complement fixation are implicated in the atherogenic effects of immune complexes.
- Down-regulation of cholesterol 27-hydroxylase by immune factors represents a potential mechanism driving atherosclerosis development.
Abstract:
The enzyme cholesterol 27-hydroxylase, expressed by arterial endothelium and monocytes/macrophages, is one of the first lines of defense against the development of atherosclerosis. By catalyzing the hydroxylation of cholesterol to 27-hydroxycholesterol, which is more soluble in aqueous medium, the enzyme promotes the removal of cholesterol from the arterial wall. Prior studies have suggested that immune reactants play a role in the pathogenesis of atherosclerosis; we report here that immune reactants, IFN-gamma and immune complexes bound to C1q, but not interleukin-1 and tumor necrosis factor, diminish the expression of cholesterol 27-hydroxylase in human aortic endothelial cells, peripheral blood mononuclear cells, monocyte-derived macrophages, and the human monocytoid cell line THP-1. In addition, our studies demonstrate that immune complexes down-regulate cholesterol 27-hydroxylase only after complement fixation via interaction with the 126-kD C1qRp protein on endothelial cells and THP-1 cells. These results are consistent with the prior demonstration that IFN-gamma contributes to the pathogenesis of atherosclerosis and suggest a role for C1q receptors in the atherogenic process. Moreover, these observations suggest that one mechanism by which immune reactants contribute to the development of atherosclerosis is by down-regulating the expression of the enzymes required to maintain cholesterol homeostasis in the arterial wall.
More Related Videos
Related Concept Videos
Inflammation
Lipid-derived Compounds in the Human Body
Fat-soluble Vitamins
Fat-soluble vitamins, including vitamins A, D, E, and K, are required in minimal quantities, but their deficiencies can lead to severely abnormal physiological conditions. For example, vitamin A deficiency can cause night blindness, dry skin, delayed...
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Cholesterol: Significance and Regulation
Considering cholesterol and...
Chronic Inflammation: Introduction

